Atlas Trials

A Study to Determine the Abuse Potential of Seltorexant Compared to Suvorexant and Zolpidem

Clinical trial NCT05106153 · COMPLETED

Trial details

NCT number
NCT05106153
Sponsor
Janssen Research & Development, LLC
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy Non-dependent, Recreational Sedative UsersAbuse Potential
Start date
2021-12-17
Primary completion
2023-05-12
Enrollment
127

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.